Abstract
CRPS is a very debilitating disorder. Pain (sensory) motor & autonomic changes are the main stream manifestation of this disorder. In this case study we employed Botoulinum Toxin-A along with routine pharmacotherapy to observe its Impact on patient’s pain intensity along with quality of life. On McGill pain scale and SF-36 QoL result showed improvement after 2nd week till 12th week. Change in each variable was significant over 12 weeks interval.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
